In the UK, Graham Phillips describes himself as the pharmacist who gave up drugs and runs two pharmacies, in Letchworth and Broadstairs, that offer a prolongevity programme that promotes weight loss through natural means, such as cutting out ultra-processed foods and monitoring blood glucose levels
These minor changes are often made solely to create the illusion that the patient requires a unique compounded formulation when, in reality, they do not. Whats particularly telling is that many compounding pharmacies are offering the same additives or minor adjustments to large numbers of patientsi.e., mass personalizationwhich clearly demonstrates a violation of FDA requirements for individualized compounding. FDA, Eli Lilly and Novo Nordisk Agree on Compounded GLP-1 Medications The FDA makes it clear: providers should not sell or market compounded GLP-1 medications like semaglutide and tirzepatide unless a patient has a legitimate, documented clinical need
Orforglipron utilizes a unique chemical scaffold to mimic the action of natural GLP-1 without being a peptide itself
For many people, this leads to the addition of acid-suppressing medications such as proton pump inhibitors (PPIs) or H2 blockers to manage symptoms
These findings suggest that GHK-Cus anti-inflammatory action is mediated, at least in part, by modulating the p38 MAPK and NF-B signaling pathways [1]
